CJC-1295
PH-CJC1295-001
Specifications
Description
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) with a Drug Affinity Complex (DAC) that extends its half-life. This long-acting peptide produces sustained elevation of GH and IGF-1 levels.
Mechanism of Action
CJC-1295 binds to GHRH receptors on pituitary somatotrophs, stimulating sustained GH release. The DAC modification enables binding to serum albumin, dramatically extending the half-life to 6-8 days (Teichman et al., 2006). This produces continuous GH elevation rather than pulsatile release.
Research Applications
- Long-acting GH secretion studies (Teichman et al., 2006)
- IGF-1 elevation and sustained GH research
- Body composition and metabolic studies
- Growth hormone axis modulation
- Combined with GHRP synergy studies
Product Specifications
- Purity: ≥99% (HPLC verified)
- Molecular Weight: 3647.28 Da (without DAC)
- Form: Lyophilized powder
- Storage: -20°C, protected from light
References
- Teichman SL, et al. J Clin Endocrinol Metab. 2006. PMID: 16352683
Documentation
Storage and Handling
- ❄️ Store lyophilized peptide at -20°C or below
- 🔒 Protect from light and moisture
- 🌡️ Allow vial to reach room temperature before opening
- 💧 Reconstitute with appropriate sterile solvent
- 📦 Aliquot to avoid repeated freeze-thaw cycles
Research Overview
CJC-1295 is a synthetic peptide compound used in laboratory research settings. Researchers studying growth hormone releasing hormone pathways use this compound to investigate cellular signaling pathways, receptor binding affinities, and structure-activity relationships. Each batch is manufactured under controlled conditions and verified through HPLC and mass spectrometry analysis to ensure consistency across experimental replicates.
Documentation & Resources
- Certificate of Analysis for CJC-1295 — batch-specific purity and identity verification
- Research Blog — protocols, guides, and peptide research literature
- Research Use Policy — handling and compliance guidelines
